Right man, right time, right place? - On the time course of the mediator orchestra in septic shock

Critical Care

Volumn 14, Issue 4, 2010, Pages

  Hauser, Balázs ^a   Radermacher, Peter ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); REACTIVE OXYGEN METABOLITE;

DNA DAMAGE; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART FUNCTION; MEDIATOR; NITROSATIVE STRESS; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS PNEUMONIA; SEPTIC SHOCK; TIME; TREATMENT PLANNING; ANIMAL; DISEASE MODEL; HUMAN; INTENSIVE CARE; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INTENSIVE CARE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN SPECIES; SHOCK, SEPTIC; TIME FACTORS;

EID: 79952115262     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9219     Document Type: Note

References (18)

1. Lange M, Connelly R, Traber DL, Hamahata A, Nakano Y, Esechie A, Jonkam C, von Borzyskowski S, Traber LD, Schmalstieg FC, Herndon DN, Enkhbaatar P. Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis model. Crit Care 2010, 14:R129. 10.1186/cc9097, 20602787.
2. Hollenberg SM, Cinel I. Bench-to-bedside review: nitric oxide in critical illness - update 2008. Crit Care 2009, 13:218. 2750127, 19664175, 10.1186/cc7706.
3. Szabó C, Modís K. Pathophysiological roles of peroxynitrite in circulatory shock. Shock 2010,
4. Reade MC, Young JD. Of mice and men (and rats): implications of species and stimulus differences for the interpretation of studies of nitric oxide in sepsis. Br J Anaesth 2003, 90:115-118. 10.1093/bja/aeg033, 12538363.
5. Hauser B, Bracht H, Matejovic M, Radermacher P, Venkatesh B. Nitric oxide synthase inhibition in sepsis? Lessons learned from large animal studies. Anesth Analg 2005, 101:488-498. 10.1213/01.ANE.0000177117.80058.4D, 16037166.
6. Hauser B, Gröger M, Ehrmann U, Albicini M, Brückner UB, Schelzig H, Venkatesh B, Li H, Szabó C, Speit G, Radermacher P, Kick J. The PARP-1 inhibitor INO1001 facilitates hemodynamic stabilization without affecting DNA repair in porcine thoracic aortic cross-clamping induced ischemia/reperfusion. Shock 2006, 25:633-640. 10.1097/01.shk.0000209561.61951.2e, 16721272.
7. Gerö D, Szabó C. Poly(ADP-ribose) polymerase: a new therapeutic target?. Curr Opin Anaesthesiol 2008, 21:111-121. 10.1097/ACO.0b013e3282f63c15, 18443476.
8. Maybauer DM, Maybauer MO, Szabó C, Cox RA, Westphal M, Kiss L, Horvath EM, Traber LD, Hawkins HK, Salzman AL, Southan GJ, Herndon DN, Traber DL. THE PEROXYNITRATE CATALYST WW-85 IMPROVES PULMONARY FUNCTION IN OVINE SEPTIC SHOCK. Shock 2010,
9. McGown CC, Brown NJ, Hellewell PG, Reilly CS, Brookes ZL. Beneficial microvascular effects of pravastatin during sepsis involve nitric oxide synthase III. Br J Anaesth 2010, 104:183-190. 10.1093/bja/aep361, 20086063.
10. Bougaki M, Searles RJ, Kida K, De Yu J, Buys ES, Ichinose F. NOS3 protects against systemic inflammation and myocardial dysfunction in murine polymicrobial sepsis. Shock 2009,
11. Huttunen R, Hurme M, Laine J, Eklund C, Vuento R, Aittoniemi J, Huhtala H, Syrjänen J. Endothelial nitric oxide synthase G894T (GLU298ASP) polymorphism is associated with hypotension in patients with E. coli bacteremia but not in bacteremia caused by gram-positive organism. Shock 2009, 31:448-453. 10.1097/SHK.0b013e318188e58e, 18827745.
12. Matejovic M, Krouzecky A, Martinkova V, Rokyta R, Kralova H, Treska V, Radermacher P, Novak I. Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock 2004, 21:458-465. 10.1097/00024382-200405000-00010, 15087823.
13. Enkhbaatar P, Murakami K, Traber LD, Cox R, Parkinson JF, Westphal M, Esechie A, Morita N, Maybauer MO, Maybauer DM, Burke AS, Schmalstieg FC, Hawkins HK, Herndon DN, Traber DL. The inhibition of inducible nitric oxide synthase in ovine sepsis model. Shock 2006, 25:522-527. 10.1097/01.shk.0000209525.50990.28, 16680018.
14. Su F, Huang H, Kazuki A, Occhipinti G, Donadello K, Piagnarelli M, De Backer D, Vincent JL. Effects of a selective iNOS inhibitor versus norepinephrine in the treatment of septic shock. Shock 2010,
15. Enkhbaatar P, Lange M, Nakano Y, Hamahata A, Jonkam C, Wang J, Jaroch S, Traber LD, Herndon DN, Traber DL. Role of neuronal nitric oxide synthase in ovine sepsis model. Shock 2009, 32:253-257. 10.1097/SHK.0b013e318193e2ba, 19008779.
16. Lange M, Connelly R, Traber DL, Hamahata A, Cox RA, Nakano Y, Bansai K, Esechie A, von Borzyskowski S, Jonkam C, Traber LD, Hawkins HK, Herndon DN, Enkhbaatar P. Combined neuronal and inducible nitric oxide synthase inhibition in ovine acute lung injury. Crit Care Med 2009, 37:223-229. 10.1097/CCM.0b013e3181926104, 19050630.
17. Matejovic M, Krouzecky A, Rokyta R, Radej J, Kralova H, Treska V, Radermacher P, Novak I. Effect of combining inducible nitric oxide synthase inhibitor and radical scavenger during porcine bacteremia. Shock 2007, 27:61-68. 10.1097/01.shk.0000235088.53421.6f, 17172982.
18. Barth E, Radermacher P, Thiemermann C, Weber S, Georgieff M, Albuszies G. Role of iNOS in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock. Crit Care Med 2006, 34:307-313. 10.1097/01.CCM.0000199070.46812.21, 16424707.